Search

everythinglearnresearchcommunity

for

Search:↓

PCOS in teens is hard to diagnose, linked to genetics and lifestyle, and managed with weight loss and medication.

Women with PCOS who have low SHBG are more likely to have low good cholesterol and metabolic syndrome.

SAHA syndrome is a condition in women involving skin and hair issues, often related to hormonal imbalances, and is treated based on the underlying cause.

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

The conclusion is that the best initial treatment for hirsutism is usually oral contraceptives, with the addition of antiandrogens or insulin sensitizers if needed, and topical eflornithine or laser treatments as supplementary options.

Female pattern hair loss is common, linked to polycystic ovarian syndrome, and treated with topical Minoxidil.

The research found that anovulatory young women have higher androgen and hormone levels than those who ovulate, suggesting immature hormonal regulation rather than a specific condition.

Finasteride increases hair density in female androgenetic alopecia, but individual results may vary.

Use "female pattern hair loss" term, assess androgen excess, treat with minoxidil and other medications if needed.

Women with regular menstrual cycles and PCOS have linked kisspeptin and LH hormone patterns, unlike those with irregular cycles.

Hormone imbalances can cause specific skin changes, which may help in early detection of endocrine disorders.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

The conclusion is that hirsutism should be diagnosed and treated because it affects quality of life and may signal other health problems.

PCOS affects about 6.3% of teens globally, and ongoing checks are advised for those with irregular cycles or high androgen levels.

Alopecia is linked to various health and mental conditions, impacts life quality, and needs medical attention beyond its cosmetic effects.

Hirsute women have lower type 2 17β-HSD enzyme levels, which improve with treatment.

New treatments for PCOS are improving fertility and managing symptoms better.

Obese women with PCOS have more cardiovascular risk factors, and waist-to-stature ratio is a better health marker than waist-to-hip ratio.

Birth control pills help treat skin and hair growth problems linked to high male hormone levels.

Flutamide combined with a low-dose birth control pill effectively reduces excessive hair growth in women with polycystic ovarian disease.

Certain brain hormones and chemicals are linked to the development of Polycystic Ovary Syndrome.

Effective hirsutism management requires identifying the cause, combining new and traditional treatments, and setting realistic expectations for patients.

Trichoscopy helps diagnose frontal fibrosing alopecia, even with unusual patterns.

The estradiol valerate/dienogest oral contraceptive helps with heavy periods, may improve acne and symptoms in PCOS, and doesn't affect sexual function.

The article concludes that global standardization in PCOS research is crucial for accurate diagnosis and understanding of the condition.

Hormones affect skin aging and fat distribution, and treatments can help, but only minoxidil is proven for female hair loss.

Belly fat is the main predictor of nonalcoholic fatty liver disease in both women with Polycystic ovary syndrome and healthy women.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Skin diseases linked to insulin resistance should be managed to prevent diabetes and reduce heart disease risk.

Hirsutism is too much hair growth in women like the pattern in men, often caused by high male hormones, and can be treated with hormone control and hair removal methods.